相似文献
1
In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes.
Eur J Pharm Sci. 2010 Sep 11;41(1):163-72. doi: 10.1016/j.ejps.2010.06.004. Epub 2010 Jun 11.
2
Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
J Mass Spectrom. 2004 Jun;39(6):672-81. doi: 10.1002/jms.640.
3
In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands.
Drug Metab Dispos. 2005 Apr;33(4):508-17. doi: 10.1124/dmd.104.001974. Epub 2004 Dec 22.
4
Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.
Drug Test Anal. 2016 Oct;8(10):1039-1048. doi: 10.1002/dta.1938. Epub 2016 Jan 26.
5
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Br J Pharmacol. 2003 Jun;139(4):775-86. doi: 10.1038/sj.bjp.0705304.
6
In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist.
Drug Metab Dispos. 2002 Oct;30(10):1077-86. doi: 10.1124/dmd.30.10.1077.
7
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.
FEBS Lett. 2003 Feb 11;536(1-3):157-60. doi: 10.1016/s0014-5793(03)00048-6.
8
In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
Drug Metab Dispos. 2007 Dec;35(12):2252-61. doi: 10.1124/dmd.107.016998. Epub 2007 Sep 21.
9
In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Drug Metab Dispos. 2009 May;37(5):1046-55. doi: 10.1124/dmd.108.025551. Epub 2009 Feb 5.
10
Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Drug Metab Dispos. 2007 Jul;35(7):1042-9. doi: 10.1124/dmd.106.014597. Epub 2007 Apr 2.
引用本文的文献
1
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.
Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102.
本文引用的文献
1
Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
Drug Discov Today. 2009 Feb;14(3-4):120-33. doi: 10.1016/j.drudis.2008.11.002. Epub 2008 Dec 26.
2
BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis.
Inflamm Res. 2008 Apr;57(4):157-62. doi: 10.1007/s00011-007-7141-z.
3
Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
Drug Metab Dispos. 2007 Jul;35(7):1135-41. doi: 10.1124/dmd.106.012906. Epub 2007 Apr 12.
4
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
Calcif Tissue Int. 2007 Jan;80(1):50-9. doi: 10.1007/s00223-006-0171-7. Epub 2007 Jan 4.
5
Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS.
Anal Bioanal Chem. 2006 Nov;386(5):1345-55. doi: 10.1007/s00216-006-0717-6. Epub 2006 Sep 6.
6
In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands.
Drug Metab Dispos. 2005 Apr;33(4):508-17. doi: 10.1124/dmd.104.001974. Epub 2004 Dec 22.
7
Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
J Mass Spectrom. 2004 Jun;39(6):672-81. doi: 10.1002/jms.640.
8
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Drug Metab Dispos. 2004 Feb;32(2):246-58. doi: 10.1124/dmd.32.2.246.
9
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Br J Pharmacol. 2003 Jun;139(4):775-86. doi: 10.1038/sj.bjp.0705304.
10
Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
J Mass Spectrom. 2003 Apr;38(4):357-72. doi: 10.1002/jms.481.
Zotero 插件